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Summary Cervical cancer incidence and mortality can be reduced by removal of precursor lesions detected at
cytological screening. Organised screening, i.e. regular invitation of defined target groups, is generally
considered more effective than opportunistic screening. The latter method however, is predominant in most
settings. There is no scientific basis for advocating one type ofscreening or the other. Our aim was to compare
the two types and to analyse their efficiency. We analysed 466 275 smears taken in an open cohort of 118 890
women during 1969-88. A computerised database permitted standardised classification of all smears and
complete ascertainment of cancer in situ through record linkage. The number of in situ cancers detected per
1000 smears, the detection ratio, was used as an outcome measure both in univariate analyses and in
multivariate logistic regression models. Cancer in situ was detected in 1076 women in the study cohort, with a
detection ratio of 3.0 at organised and 2.1 at opportunistic screening, yielding an unadjusted odds ratio of0.69
(95% CI 0.61-0.79). After adjustment for age and time period, the probability of detecting cancer in situ was
around 25% higher with opportunistic than with organised screening (OR = 1.26; 95% CI 1.09-1.46). This
difference in favour of opportunistic screening was most pronounced in the first 10 year period and
disappeared during the last decade. The difference in efficiency between organised and opportunistic screening
in the detection of cancer in situ was slight, if any. The dogma that organised screening is significantly more
efficient than the opportunistic type needs reconsideration.
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Organised cytological screening - in which defined target
groups are regularly invited for screening - is generally
considered the most efficient tool for reducing the incidence
of cervical cancer and its mortality (Hakama, 1982, 1986;
Draper and Cook, 1983; IARC, 1986; Liiiirii et al., 1987;
Anderson et al., 1988; Hakama and Louhivuori, 1988; Day,
1989; Lynge et al., 1989, 1992; Storm and Jensen, 1989;
Koopmanschap et al., 1990a,b; Miller et al., 1991a,b;). It is
assumed to reach the whole female population, particularly
women at high risk, more completely than opportunistic
screening, which is carried out on the woman's or physician's
initiative (Hakama, 1986; Liaara et al., 1987; Hakama and
Louhivuori, 1988; Day, 1989; Miller et al., 1991b). Inves-
tigators assume that the successful screening in several Nor-
dic countries, mainly Finland and Sweden, is the result of
good organisation (Draper and Cook, 1983; Day, 1984, 1989;
Hakama and Louhivuori, 1988; Storm and Jensen, 1989) and
that the failure of screening in Great Britain, for example, is
due to poor organisation (Cook and Draper, 1984; Hakama,
1986; Murphy et al., 1987; Day, 1989). We found only one
paper with a different view (Pettersson et al., 1985).
Belief in the advantages of organised screening may not be
well founded, however, since smears taken outside organised
programmes account for a major part of the successful
screening activity in, for instance, Finland and Sweden.
Indeed, to our knowledge, no quantitative comparisons of
organised and opportunistic screening have been reported.
There is also strong evidence that screening has in fact had
an effect even in Great Britain, although the benefit has been
partly concealed by birth cohort effects on the incidence, and
limited by organisational defects, low coverage and incom-
plete diagnostic work-up (Hill and Adelstein, 1967; Chamber-
lain, 1984; Cook and Draper, 1984; Elwood et al., 1984;
Parkin et al., 1985; Knox and Woodman, 1988; NHS Cer-
vical Screening Programme, 1991).
Our aim was to estimate the separate effects of organised
and opportunistic screening in detecting cancer in situ in a
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Swedish setting. When screening started in the late 1960s in
Sweden, women between the ages of 30 and 49 years were
invited to attend for cytological testing every 3-4 years.
Nevertheless, smears taken outside the organised programme
soon accounted for 75-80% of all smears. This setting pro-
vided an opportunity to compare organised and opportunis-
tic screening regarding the probability of detecting cancer in
situ. We restricted our study to the county of Uppsala in
central Sweden, which offers a computerised register of data
on cytological smears taken since 1969.
Materials and methods
Setting
The public medical service in Sweden is divided into 26
financially and administratively independent areas. Charges
for medical services are kept low enough to permit all citizens
equal access to public health care. Screening for cervical
cancer started on a limited scale in 1961, and an organised
programme was introduced in November 1967. In the begin-
ning all women aged 30-49 (later 25-49) years were invited
to attend every 3-4 years. Initially the organised screening
was run independently of opportunistic screening. However,
since 1972 only women with no smears registered during the
last 3-4 years have been invited for screening. The comp-
liance has declined from 60% to 50% over the study period.
In the organised programme smears are taken by specially
trained midwives.
The female population of the county of Uppsala in central
Sweden increased from 100 200 in 1969 to 131 400 in 1988.
All smears taken in the county are classified according to the
Papanicolaou scheme (Papanicolaou and Traut, 1943; Papa-
nicolaou et al., 1948; Papanicolaou, 1954) into five groups
ranging from normal (Pap 1) to squamous carcinoma (Pap
5). Women with a slightly abnormal smear or with
cytological abnormalities (Pap ) 3) are invited to have a
second smear taken, usually within 3 months. Those who do
not attend are reminded after 6 months.
In the organised programme a more active follow-up isCytological screening for cervical cancer
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initiated in certain subgroups of women. After a year without
a recommended second smear, women are again invited to
attend screening. Women who use oral contraceptives or
IUDs, or show cytological evidence of infection, are invited
after 2 years. Hence, during the 1980s the organised system
became a 'safety system' for women not considered to be
participating sufficiently in opportunistic smear-taking. The
organised programme only includes residents of the county,
while opportunistic screening is available for all women.
The diagnostic work-up and treatment of cancer in situ are
standardised and thus independent of whether the initial
smear was taken during organised or opportunistic screening.
In the early period women with slight abnormalities or even
Pap 3 were followed up without intervention. Gradually it
became routine to take a biopsy after two smears classified as
slightly abnormal or after one Pap 3. If the biopsy revealed
cancer in situ or severe dysplasia (and later also moderate
dysplasia) the woman was treated by surgical conisation.
This schedule was followed until 1976; during 1977 and 1978
cryosurgical treatment replaced surgery, and after 1978 laser
conisation became the standard therapy. Hysterectomy has
not been used to treat precursors to cervical cancer in
Sweden. In the Uppsala county around 10% of the women
undergo hysterectomy during their lifetime.
The cytology register
From 1969 all smears taken at organised screening, and from
1971 smears from all sources, were registered on a computer.
Each woman is identifiable through her individually unique
national registration number, which contains the date of
birth. Each smear is characterised by grading of atypia (Pap
code), a tag for organised screening, information on previous
treatment, date and place of smear-taking, name of labor-
atory, and clinical information (presence of inflammation,
microbiological classification). For quality control purposes,
every tenth smear is double checked independently by two
cytotechnicians. All specimens showing atypia are also read
by a cytologist. A number of checks are used to exclude
incompleteness and errors in the data. The cytology register
is synchronised with the data for gynaecological and other
histopathological material, allowing comparative investiga-
tions. The register is almost complete and contains few
coding errors. In our analyses only 0.005% of all smears
could not be properly handled because of missing inform-
ation, for example the date of smear-taking or the Pap code.
Smears taken independently of any previous smear were
denoted primary. Smears taken as a direct consequence of a
previous one - usually because this was uninterpretable or
abnormal - were denoted secondary. We used register in-
formation to classify each smear into any of five mutually
exclusive categories, namely: organised primary, organised
secondary, opportunistic primary, opportunistic secondary
and follow-up. Our interest lay in the primary smears that
led to detection and treatment of cancer in situ. Whenever a
secondary smear had been taken as part of a diagnostic
work-up, the benefit, if any, was ascribed to the primary
smear. We classified all primary and secondary smears as
taken at organised or opportunistic screening. Smears taken
after treatment were classified as follow-up smears and were
not used in this study.
A computer algorithm was used to classify all smears.
Primary smears taken at organised screening were already
tagged and readily identifiable. For the remaining smears,
information about the women's earlier screening histories
was used to separate them into categories. A smear taken 6
months or more after a preceding one was always classified
as primary.
To validate the computer algorithm for classification of
smears, we systematically studied about 2000 screening his-
tories, with oversampling of women with cancer in situ. The
most problematic cases were discussed with cytology experts.
Manual classification was then compared with that accomp-
lished by the computer program. We revised the program
several times until the manual and computerised classification
were in almost complete agreement.
Ascertainment ofcancer in situ
Since 1958, all physicians in Swedish hospitals and other
establishments for medical treatment under public as well as
private administration have reported cases of diagnosed
cancer to the national cancer registry. In addition, patho-
logists and cytologists separately report every cancer diag-
nosis based on surgical specimens and autopsies. Thus, the
majority of cases are notified twice to the registry (National
Board of Health and Welfare, 1973-91). The cancer registry
also demands reporting of 'cancer in situ and severe dysplasia
which is on the borderline of this' (Medicinalviisendet, 1968;
SOSFS, 1982, 1984).
Definition ofstudy cohort
The national registration numbers were used to link the
cytology register to the national cancer register. Information
from the cancer register was copied into the cytology register.
A total of 1655 cases of cancer in situ had been registered in
the study cohort during follow-up in 1969-88. All smears
taken after a diagnosis of cancer in situ or invasive cervical
cancer (19 991 smears) were excluded from the analysis.
We lack information about migration to and from the
county of Uppsala. A large number of women lived there for
only a few years, e.g. when studying at one of the two
universities. Some of these women were screened within the
county but had cancer in situ detected outside the county.
These women were included in the study cohort if the
preceding smear had been taken within the county less than 1
year before their cancer in situ was diagnosed. This procedure
excluded another 522 women (and 1129 registered smears),
mostly women who had had a single smear taken within the
county several years before the diagnosis of cancer in situ.
The vast majority of these women would not have been
included if we had accepted only the cancer in situ cases that
were diagnosed inside the county of Uppsala. However, we
would then have lost a few cases whose screening history we
already knew. Women with cancer in situ confirmed within
the county, but without sufficiently ascertained screening his-
tories in the cytology register, were not included.
For each woman with a detected cancer in situ we used an
algorithm to identify the preceding smear that led to the
detection. The woman's file of smears was read backwards
over time until a smear classified as slightly abnormal or
worse was found. We excluded from the analyses 32 women
with cancer in situ whose smears could not be classified
reliably. The study cohort finally comprised 118 890 women
with 466 275 primary smears, and among these women there
were 1076 cases of cancer in situ.
To test whether women at high risk ofdeveloping cancer in
situ selectively chose organised or opportunistic screening, we
examined women (born 1940-44) with m organised vs n
opportunistic smears for m, n = 0,1,2. . . Among 12 615
women, 70% of those with two smears or more had had at
least one of them in each category. In women with at least
three smears this figure was 75%. By plotting histograms
(data not shown) for women with the same number of
smears, we found that participation in only organised or only
opportunistic screening was rare.
Statistical methods
As a measure of the outcome, we chose the number of
cancers in situ per 1000 primary smears, referred to below as
the detection ratio. Age standardisation was performed to the
Swedish census 1970 (National Board of Health and Welfare,
1973-91).
In the modelling of factors that influenced the probability
of obtaining a diagnosis of cancer in situ, the logistic regres-
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sion model was used. Denoting this probability P, the model
assumes that
ln P/(1- P) = Po + PfX1 + ... + kXk
where XI, . . . Xk represent the explanatory variables type of
screening, period, age and time interval since previous smear.
The explanatory variables were used in categorised form,
with categories as shown in Table III. The model was
estimated by the maximum likelihood method. From the
estimated beta parameters and standard errors, odds ratios
with confidence intervals were computed. For the present
data the odds ratios are almost identical to relative risks. The
standard version of the model requires independence between
observation units. However, in the present case women are
only included in the study until the registration of the first
cancer in situ diagnosis. This means that the modelling can
be seen as an application of the discrete time proportional
hazards model. In this case results from the standard logistic
regression model are valid even if more than one smear is
included from a woman (Breslow, 1992).
Dynamic modelling
The detection ratio would not adequately reflect the benefit
of screening if the probability of progression to invasive
cancer differs between cancers in situ detected by organised
and those detected by opportunistic screening. Since the
mean interval between two smears was longer for organised
than for opportunistic screening (see below), it was important
to investigate to what extent this might have affected the
probability of progression.
We used a dynamic simulation model, previously described
in detail (Gustafsson and Adami, 1989), to estimate the
proportion of progressing cancers in situ associated with
screening intervals of 1.9 and 3.3 years and with different
screening sensitivities. The compartmental model describes
the dynamic process from a healthy state, to preinvasive
cancer, to preclinical invasive cancer, to clinical invasive
cancer. In this model, the detection (and elimination) of
cancer in situ was the determinant of the subsequent reduc-
tion in the incidence of invasive cancer. Our model,
previously fitted to Swedish data, provided estimates of
sojourn times, percentages of progression and regression of
cancer in situ (Gustafsson and Adami, 1989) and the benefits
of screening (Gustafsson and Adami, 1990). By running this
model until a 'steady state' was reached and then by remov-
ing a certain proportion of cancers in situ (determined by an
assumed test sensitivity), the situation after screening was
simulated.
To estimate the effect of renewed screening a certain
number of years after the preceding one, we ran the model
for another 1.9 and 3.3 years, and once again removed a
proportion of the cancer in situ cases determined by the
smear test sensitivity. Without screening, a proportion of
these removed cancer in situ cases would have progressed to
invasive cancer. This proportion could be calculated for the
different time intervals when the removed cancers in situ are
run through the dynamic model. We also ran the model for
different assumptions of smear test sensitivity. For further
details, see Gustafsson and Adami (1989).
Results
Screening activity
The number of smears, the number of cancers in situ and the
detection ratio at organised and opportunistic screening are
shown in Table I. The total number of smears taken in-
creased from about 15 000 in 1969 to between 30000 and
35 000 annually after 1976. From 1976 opportunistic screen-
ing accounted for more than 80% of all smears. The overall
proportions in the cytology register were 87.5% primary,
4.5% secondary and 8.0% follow-up smears. The primary
smears at organised screening showed a fairly constant age-
standardised rate of about 40 smears per 1000 women-years,
while the rate at opportunistic screening rose from about 80
in 1971 to about 200 smears per 1000 women-years from
1976 (Figure 1).
Table 1 Numberofsmears, numberofdiagnosedcasesofcancerinsituanddetectionratioat
organised and opportunistic cytological screening in the county of Uppsala, Sweden,
1969-88
Characteristics
Primary smears
Secondary smears
Sum
Follow-up
Follow-up after in situ
Erroneous
Excluded
Total
Number offirst smears
( + 5 missing)
Cancer in situ
Detection ratio
per 103 primary smears
1969-88
1969-78
1979-88
Detection ratio for
first smear per 103
smears
Detection ratio for
first smear per 103
smears for age 25-50
and 1971-88
Mean age at screening
(years)
Mean elapsed time
since previous smear (years)
Organised
screening
103 156
4 423
107 579
41 643
312
3.02
4.64
2.29
4.30
4.49
35.6
Opportunistic
screening
363 119
19 492
382 611
77 242
764
2.10
4.89
1.42
3.22
5.55
37.7
3.34 1.91
00
500
Total
screening
466 275
23 915
490 190
19 991
22 583
14
1 129
533 907
118 885
1 076
2.31
4.00
5.08Total screening
:'Opportunistic
Xr-. --
Organised
1970 1975 1980
Year
1985
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Figure 1 Age-standardised rates of primary smears taken each
year at organised and opportunistic screening and in total during
1969-88 in the county of Uppsala.
Figure 2 The age-specific rates of primary smears per 000
women for organised, opportunistic and total screening during
1969-88 in the county of Uppsala.
The age-specific rates of primary smears are shown in
Figure 2. The organised programme covered mainly ages
25-49, while opportunistic screening included a wider age
span. From age 20-25 the overall rate was over 350 per 1000
women a year and remained on this level until age 45-50,
whereafter a rapid decline took place. The age-specific rates
of primary smears were largely similar during the 5 year
periods 1969-73, 1974-78, 1979-83 and 1984-88 (data not
shown).
Detection ratios
In a series of 103 156 primary smears taken at organised
screening, 312 cases of cancer in situ were diagnosed. The
corresponding numbers at opportunistic screening were
363 119 primary smears and 764 cancers in situ. Hence, the
overall detection ratio was 2.3 cases of cancer in situ per 1000
primary smears, 3.0 at organised and 2.1 at opportunistic
screening (Table I). The detection ratio decreased over time.
For a few years it was more than 5 per 1000 primary smears
at both organised and opportunistic screening. This was fol-
lowed by a steady decrease to between 1.5-2 per 000 in the
mid-1980s (Figure 3a). When adjusted for age, the detection
ratio was higher at opportunistic than at organised screening
until 1978, and similar thereafter (Figure 3b).
The age-specific detection ratios peaked around ages
25-35, and rapidly declined (Figure 4). At ages 35-50, the
ratio was somewhat higher at organised than at opportunistic
screening. The data were further analysed separately for the
10 year periods 1969-78 and 1979-88 (data not shown). In
the first period the detection ratios peaked at about 5 per
1000 smears; during the second they were about 2 per 1000
smears.
Figure Sa shows the distribution of smears by time interval
since the previous smear (of any kind) for all primary smears
taken at organised and opportunistic screening during
1971-88 in women aged 25-50. Since the first registered
smear had no predecessor, the numbers of first smears for
organised and opportunistic screening are shown separately.
At opportunistic screening, the elapsed time was typically
0-3 years with an average of 1.9 years (first screening not
included). At organised screening, the intervals were longer,
mostly 1.5-6 years with an average of 3.3 years. We also
compared the detection ratios for organised and opportunis-
tic screening by time interval since previous smear. The
detection ratios at organised and opportunistic screening
were about the same over most of the time intervals (Figure
5b).
Multivariate analyses
Multivariate modelling was used to analyse simultaneously
the effect of different factors associated with the likelihood of
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detecting cancer in situ in a smear. The fit of the multivariate
model improved significantly after stepwise inclusion of
screening type (organised or opportunistic), age, time period
and time interval since the previous smear was taken. A
further improvement was achieved when an interaction
between screening type and time period was allowed. The fit
of the final model (type of screening + age + time period +
elapsed time + type of screening x time period) was excellent,
as indicated by a deviance close to the number of degrees of
freedom (Table II).
Without adjustment, opportunistic screening was 31% less
efficient than organised screening in detecting cancer in situ
(OR = 0.69; 95% CI 0.61-0.79) (Table III). When adjusted
for age and time period we obtained an OR of 1.26 (95% CI
1.09-1.46). After additional adjustment for time interval
since previous smear, opportunistic screening was overall
45% more likely to detect cancer in situ (OR = 1.45; 95% CI
1.24-1.70) than was organised screening. The significant
interaction term between screening type and time period
indicates, however, that the efficiency of opportunistic com-
pared with organised screening varied markedly over time.
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Figure 5 (a) Histogram of time interval since previous smear of
any kind for primary smears, and the corresponding bar for first
smear during 1971-88 for women of ages 25-50 in the county of
Uppsala. The bars for opportunistic smears (0) are on top of
those for organised smears (-). (b) Detection ratios of cancer in
situ per time interval since previous smear, and the corresponding
ratios for first smear.
The odds ratios of detecting cancer in situ for opportunistic
compared with organised screening were 2.19 (95% CI
1.75-2.73), 1.39 (95% CI 1.03-1.87), 0.89 (95% CI
0.66-1.21) and 0.75 (95% CI 0.52-1.09) in the 5 year time
periods from 1969 to 1988 (Table III). Hence, opportunistic
screening was superior during the first decade, whereas the
effect of the two types of screening was largely similar during
the last decade.
The model also provided estimates of the effects of time
period, time interval since previous smear and age on the
probability of detecting cancer in situ (Table III). In
univariate analysis, the probability was more than five times
higher during the first than during the last 5 year period,
with a regular trend (Table III). The effect of time since the
previous smear was analysed with more than 5 years as the
reference group. The likelihood of detecting cancer in situ
was reduced markedly and highly significantly during the first
4 years after a smear, whereafter it approached the reference
category. The relatively high odds ratios within the first year,
evident also in Figure 5, are probably explained by a smaller
proportion of secondary smears misclassified as primary.
When age 30-34 was used as a reference, the odds ratios
decreased successively at younger and older ages. The odds
ratio was about 0.5 at ages below 25 years and between 40
and 50 years, while it was less than 20% above the age of 50.
For more details see Gustafsson et al., 1995 (submitted).
Dynamic modelling
The dynamic model was used to investigate whether the
overall probability of progression to invasive cancer differed
between cancers in situ detected at organised screening and
those detected at opportunistic screening. This probability
depends on the time since the previous smear and the smear
test sensitivity. For organised screening the average time
interval between smears was about 3.3 years, and for oppor-
tunistic screening it was about 1.9 years. For a sensitivity of
0.90 the ratio of cases detected at organised screening that
would have progressed to invasive cancer to those detected at
opportunistic screening was 1.01. The corresponding figure
for a sensitivity of 0.75 was 0.985, and for a sensitivity of
0.50 it was 0.984.
Discussion
We used prospectively collected data to compare organised
and opportunistic screening in terms of ability to detect
cancer in situ. The study cohort comprised all women who
had been screened at least once. The time period included the
time of introduction of large scale screening, when prevalent
cases predominated, and the more stationary phase there-
after. Since it is assumed premalignant lesions are eliminated
by screening, we used cancer in situ rather than invasive
cancer as the end point. Our results would not reflect the true
impact of screening on the incidence of cervical cancer and
its mortality if cancer in situ cases detected at organised and
opportunistic screening differed in their probability of pro-
gressing to invasive cancer. The dynamic modelling sug-
gested, however, that this difference, if any, was negligible.
Hence, we propose the detection ratio as a valid measure of
TableII Results offitting logistic regression models to the detection ratios of
cervical cancer in situ in the county of Uppsala, Sweden, 1969-88
Change in
Model Deviance df. deviance df. P-value
1. General mean only 1220.4 400 27.7 1 <0.001
2. 1 + type 1174.7 399 236.4 7 <0.001
3. 2 + age 938.2 392 365.6 3 <0.001
4. 3 + time period 572.6 389 118.2 6 <0.001
5. 4 + elapsed time 454.4 383 33.5 3 <0.001
6. 5 + type x period 420.9 380
an nnnm
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Table III Odds ratios for detection ofcancer in situ of the cervix uteri, and
their approximate 95% confidence intervals in cytological smears taken in the
county of Uppsala, Sweden during 1969-88
Univariate models Multivariate model
Factor Odds ratio 95% CI Odds ratio 95% CI
Type of screening
Organised 1.00 Reference
Spontaneous 0.69 0.61-0.79
Type of screeninga
1969-73 2.19 1.75-2.73
1974-78 1.39 1.03-1.87
1979-83 0.89 0.66-1.21
1984-88 0.75 0.52-1.09
Age at screening test
(years)
<24 0.47 0.38-0.58 0.42 0.34-0.52
25-29 1.00 0.84-1.19 0.91 0.76-1.08
30-34 1.00 Reference 1.00 Reference
35-39 0.87 0.72-1.05 0.95 0.79-1.15
40-44 0.52 0.41-0.66 0.55 0.44-0.70
45-49 0.53 0.41-0.68 0.49 0.38-0.62
50-54 0.19 0.12-0.30 0.19 0.12-0.29
55 + 0.17 0.11-0.25 0.15 0.10-0.23
Time period of test
1969-73 2.25 1.93-2.62 1.67 1.21-2.30
1974-78 1.00 Reference 1.00 Reference
1979-83 0.65 0.55-0.77 1.03 0.71 -1.50
1984-88 0.40 0.33-0.48 0.74 0.49-1.12
Elapsed time since
previous smear
(years)
<1 1.05 0.79-1.39 0.81 0.60-1.10
1-2 0.44 0.32-0.59 0.37 0.27-0.51
2-3 0.43 0.31-0.60 0.35 0.25-0.50
3-4 0.72 0.51-1.03 0.59 0.41 -0.84
4-5 0.95 0.66-1.38 0.80 0.55-1.16
5 + 1.00 Reference 1.00 Reference
First smear 1.27 0.97-1.67 0.82 0.61-1.10
aForeachtimeperiodorganised screeningwasusedasthereferencecategory.
The multivariateestimates are from model 6 in Table II. This model allows the
effects of spontaneous screening to vary between time periods. Organised
screening was used as the reference category.
screening efficiency for the purpose of comparing organised
and opportunistic screening.
According to our data, opportunistic screening was as
likely to detect cancer in situ as was organised screening. The
overall similarity between the two types of screening is seen
in Figures 3 and 4, but multivariate analysis is required for a
more informative quantitative comparison. The crude odds
ratio of 0.69 - indicating a 31% lower probability of detec-
ting cancer in situ at opportunistic screening than at
organised screening - is confounded by the difference in the
distribution of the two screening types over time (Figure 1)
and age (Figure 2).
After adjustment for time period and age it became evident
that opportunistic screening was more efficient in detecting
cancer in situ than was organised screening during the first 10
years of our study. However, during the last 10 years there
was no significant difference between the two types; if any,
there was a tendency for organised screening to be more
efficient (Table III). These estimates were also adjusted for
time interval between smears. To reflect reality we would
probably prefer a model without adjustment for this variable.
In fact, this gives similar odds ratios, but indicates a smaller
advantage of opportunistic screening during the first 10 years
and a somewhat larger advantage for organised screening in
the last decade, although these estimates are still not statis-
tically significant.
The interaction between type of screening and time period
may be best understood in light of the decreasing overall
detection ratio from the first to the last 5 year period (Table
III). Several factors are likely to cause this trend. First, the
diagnostic yield should be higher during the first years after
screening was introduced since many prevalent lesions are
detected at a first screening. Secondly, the diagnostic criteria
for cancer in situ - including severe dysplasia - are vague,
vary greatly between pathologists (Bergstrom et al. 1993) and
have probably become more stringent in the county of Upp-
sala in recent years. Thirdly, it is probable that the oppor-
tunistic screening has changed from mainly smear-taking on
indication to routine examination in maternity wards and
family planning clinics. Theoretically, the negative trend in
the detection ratio may also result from a decrease in test
sensitivity or a reduction of the incidence of cancer in situ in
the screened population. These factors are unlikely to play a
practical role, however; if anything, there is evidence that the
incidence of cancer in situ has increased, at least in younger
women (Gustafsson, 1986).
We believe that subject selection is more important. Sex-
ually active women at relatively high risk of developing
cancer in situ may have been overrepresented among screened
women during the early years. They may also have been
detected more readily at opportunistic than at organised
screening. This could account for the finding that the detec-
tion ratio was approximately twice as high at opportunistic
as at organised screening during the first 5 year period but
did not differ significantly in the last decade (Table III).
Ths risk of being diagnosed with cancer in situ increases
for at least 4 years after a normal smear. The higher odds
ratio at less than 1 year may be the result of misclassification
of some symptomatic or secondary smears (Table III).
We failed to identify biases that could have concealed a
true benefit of organised screening. Indeed, organised screen-
ing was partly a safety system for women considered to be atCytological screening forcervical cancer
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high risk, as described in the Materials and methods section.
Nevertheless, more than 70% of all cancers in situ were
detected at opportunistic screening. Although we have no
empirical support, it is conceivable that the test sensitivity
differs between organised and spontaneous screening. How-
ever, the empirical evidence suggests that midwives are at
least as capable of taking smears as general practitioners
(Ahlgren et al., 1969; Bhargava et al., 1993; Mitchell, 1993).
How representative are our data? Over the years, oppor-
tunistic screening has accounted for 75-80% of all smears in
Sweden as a whole (National Board of Health and Welfare,
1982; Pettersson et al., 1985) and for 78% of primary smears
in the county of Uppsala. Screening for cervical cancer has
been as successful in the county of Uppsala as in Sweden
(National Board of Health and Welfare, 1973-91; Gustafs-
son and Adami, 1989); in the birth cohorts screened most
extensively, the incidence of and mortality from cervical
cancer have been reduced by about 70% in Sweden (Gustafs-
son and Adami, 1990). Hence our results can probably be
generalised at least to the Swedish population.
Are our data informative for those intending to start
cytological screening and for those who want to improve the
efficiency of ongoing screening, organised or opportunistic?
At least they challenge our prior belief in a definite advan-
tage of organised screening, shared by many other inves-
tigators (Hakama, 1982, 1986; Draper and Cook, 1983;
IARC, 1986; Laara et al., 1987; Anderson et al., 1988;
Hakama and Louhivuori, 1988; Day, 1989; Lynge et al.,
1989, 1992; Storm and Jensen, 1989; Koopmanschap et al.,
1990a,b). Although preference for one type of screening by
certain groups of women could not be assessed directly in
our observational study, we found no support for the idea
that opportunistic screening selectively reaches women at low
risk. Overscreening is a more evident feature of opportunistic
screening in our setting. An increase in the mean interval
between smears from less than 2 years to, say, 3 years or
longer would probably reduce the costs substantially,
whereas the benefit of screening would remain largely similar
(Gustafsson and Adami, 1992). A longer interval between
opportunistic screenings can probably be brought about
through a combination of organisational change, a well-
considered health care policy and public as well as profes-
sional education. We also believe that an important aspect of
the Swedish setting is the fact that diagnostic work-up and
treatment of abnormal smears are standardised and indep-
endent of type of screening. Therefore we regard it as impor-
tant to make similar studies in other settings and to incor-
porate also the economic aspects of type of screening before
designing a screening programme.
We wish to suggest a more optimistic view of the efficiency
of opportunistic screening. Evidently, the claim that the suc-
cessful control of cervical cancer in Sweden is attributable
mainly to organised screening is not well founded. In many
settings, a well-thought-out use of means of promoting
smear-taking initiated by women, midwives or doctors might
be an efficient way to stimulate screening in a large majority
of women and to increase the benefit of activities already in
progress.
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